VeraDermics (NYS: MANE) last raised $150.0M in its Later Stage VC (Series C) (Oct 2025).
- ·9 fund marks: filer, period, implied $/share
Membership and data by Private Market View
VeraDermics (NYS: MANE) funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Later Stage VC (Series C) | $150.0M | ▮ | ▮ |
Membership and data by Private Market View
VeraDermics (NYS: MANE) valuation
VeraDermics (NYS: MANE) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $596 million (Feb 2026). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
Recent activity
In the last 90 days, VeraDermics (NYS: MANE)'s record added 1 institutional fund mark (latest period Jul 2026).
How much has VeraDermics (NYS: MANE) raised?
VeraDermics (NYS: MANE) has raised $519 million in total; 1 of its rounds is on record. The largest on record was a $150 million Series C in Oct 2025.
Institutional holders and vehicles
4 SEC-registered funds reported 9 fair-value marks on VeraDermics (NYS: MANE) between Feb 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Superluminal Medicines ($576 million), Strand Therapeutics ($571 million) and Bambusa Therapeutics ($555 million).
How VeraDermics (NYS: MANE)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For VeraDermics (NYS: MANE), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about VeraDermics (NYS: MANE)
- What is VeraDermics (NYS: MANE) worth?
- VeraDermics (NYS: MANE)'s last known valuation is $596.3M.
- How much has VeraDermics (NYS: MANE) raised?
- VeraDermics (NYS: MANE) has raised $518.6M in total funding across 1 recorded rounds.
- When did VeraDermics (NYS: MANE) last raise?
- VeraDermics (NYS: MANE) last raised in Oct 2025 (Later Stage VC (Series C)), raising $150.0M.